Novavax, Inc

NVAXNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

164.8M

on 2026-06-30, from 140.4M on 2024-03-31 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

2 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

78 quarters

$719.3M on 2026-06-30 ÷ $9.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 3 of its filings are not read yet.

Also on file: $175.3M convertible notes, 2025-08-27 8-K ↗